Quthero
A company developing new ways of treating wounds and skin conditions .
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | $500k | Grant | |
| Total Funding | 000k | ||
Related Content
Quthero is a biotechnology company that specializes in regenerative therapies using its proprietary Q-peptide technology. The company's primary focus is on developing treatments for applications in dermatology and cardiology.
Its main product is a gel designed to promote rapid and scarless healing for various types of skin wounds, including surgical incisions, burns, and chronic ulcers. The technology works by restoring the moisture and mechanical properties of the wound. In addition to its therapeutic pipeline, the company has also launched a skincare line that incorporates its Q-peptide technology, suggesting a business model that may include both B2B (medical treatments) and B2C (skincare products) channels. The company is privately held and secures funding from investment bodies to advance its research and development.
Keywords: regenerative therapies, Q-peptide, dermatology, cardiology, tissue regeneration, wound healing, scar treatment, biotechnology, skincare, medical devices
